Europe Longevity Diagnostics Market Size & Outlook

The longevity diagnostics market in Europe is expected to reach a projected revenue of US$ 1,175.0 million by 2033. A compound annual growth rate of 6.6% is expected of Europe longevity diagnostics market from 2026 to 2033.
Revenue, 2025 (US$M)
$710.8
Forecast, 2033 (US$M)
$1,175.0
CAGR, 2026 - 2033
6.6%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe longevity diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe longevity diagnostics market highlights

  • The Europe longevity diagnostics market generated a revenue of USD 710.8 million in 2025.
  • The market is expected to grow at a CAGR of 6.6% from 2026 to 2033.
  • In terms of segment, epigenetic age testing was the largest revenue generating test type in 2025.
  • Multi-Omics Profiling is the most lucrative test type segment registering the fastest growth during the forecast period.
  • Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.


Europe data book summary

Market revenue in 2025USD 710.8 million
Market revenue in 2033USD 1,175.0 million
Growth rate6.6% (CAGR from 2026 to 2033)
Largest segmentEpigenetic age testing
Fastest growing segmentMulti-Omics Profiling
Historical data covered2021 - 2024
Base year for estimation2025
Forecast period covered2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationEpigenetic Age Testing, Telomere Length Analysis, Multi-Omics Profiling, Proteomics-Based Aging Biomarkers, Metabolomics Testing, Microbiome Aging Diagnostics, Hormone & Metabolic Profiling


Other key industry trends

  • In terms of revenue, Europe region accounted for 25.4% of the global longevity diagnostics market in 2025.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 989.1 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Longevity Diagnostics Market Companies

Name Profile # Employees HQ Website
Altos Labs View profile 251-500 San Francisco, California, United States, North America https://altoslabs.com/
WellnessFX View profile 11-50 San Francisco, California, United States, North America https://www.wellnessfx.com
Function Health View profile 11-50 Austin, Texas, United States, North America https://www.functionhealth.com
InsideTracker View profile 11-50 Cambridge, Massachusetts, United States, North America http://insideTracker.com
Tally Health View profile 11-50 New York, New York, United States, North America https://www.tallyhealth.com
GlycanAge View profile 11-50 Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe https://glycanage.com
TruDiagnostic View profile 51-100 Lexington, Kentucky, United States, North America https://trudiagnostic.com
SiPhox Health View profile 11-50 Burlington, Massachusetts, United States, North America https://siphoxhealth.com
Elysium View profile 11-50 New York, New York, United States, North America http://www.elysiumhealth.com
Abbott View profile - - -
Nebula Genomics View profile 11-50 San Francisco, California, United States, North America https://www.nebula.org
Knovos View profile 251-500 Fairfax, Virginia, United States, North America https://www.knovos.com/
23andMe Holding Co Class A View profile 816 349 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 https://www.23andme.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com

Europe longevity diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to longevity diagnostics market will help companies and investors design strategic landscapes.


Epigenetic age testing was the largest segment with a revenue share of 27.27% in 2025. Horizon Databook has segmented the Europe longevity diagnostics market based on epigenetic age testing, telomere length analysis, multi-omics profiling, proteomics-based aging biomarkers, metabolomics testing, microbiome aging diagnostics, hormone & metabolic profiling covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Europe longevity diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe longevity diagnostics market databook

  • Our clientele includes a mix of longevity diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe longevity diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe longevity diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe longevity diagnostics market size, by country, 2021-2033 (US$M)

Europe Longevity Diagnostics Market Outlook Share, 2025 & 2033 (US$M)

Europe longevity diagnostics market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online